Article

Testosterone gel now available in metered-dose pump

Unimed Pharmaceuticals said it now offers testosterone gel 1% (AndroGel) in a metered-dose pump.

Related Videos
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Man talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
1 expert is featured in this series.
Treatment Decisions in Patients With Low- vs High-Volume Disease
1 expert is featured in this series.
Findings in the Docetaxel-Naive Patient Population
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Endourologist discusses shared decision-making and laser lithotripsy
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Related Content
Hugo robot-assisted surgery system shows promise for urologic procedures
May 2nd 2025

Hugo robot-assisted surgery system shows promise for urologic procedures

Hannah Clarke
These results are expected to support submission of the Hugo system to the FDA for use in urologic procedures.
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
May 1st 2025

Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025

Amy M. Pearlman, MD
Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology.
Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland | Image Credit: @ Dr_Microbe - stock.adobe.com
May 2nd 2025

Phase 3 trial of capivasertib in mCRPC discontinued following IDMC recommendation

Hannah Clarke
The committee determined that the study was unlikely to meet its dual primary end points of radiographic progression-free survival and overall survival.
Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025
April 30th 2025

Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025

Amy M. Pearlman, MD Ryan Terlecki, MD
A discussion on evolution of surgical education, importance of video training, and the future of patient-centered care in reconstruction.
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
May 1st 2025

Safety, efficacy of vibegron sustained in men with OAB treated for BPH

Benjamin P. Saylor
The investigators reported an overall incidence of AEs of 29.6%.
FDA updates in urology: April 2025
May 1st 2025

FDA updates in urology: April 2025

Hannah Clarke
A recap of the FDA submissions and regulatory decisions in urology from April 2025.
© 2025 MJH Life Sciences

All rights reserved.